The DOI matches its Crossref record; 119 of the 119 references it cites were found in a registry or an index.
Role of monocarboxylate transporters in human cancers: state of the art
Open accessAbstract
Monocarboxylate transporters (MCTs) belong to the SLC16 gene family, presently composed by 14 members. MCT1-MCT4 are proton symporters, which mediate the transmembrane transport of pyruvate, lactate and ketone bodies. The role of MCTs in cell homeostasis has been characterized in detail in normal tissues, however, their role in cancer is still far from understood. Most solid tumors are known to rely on glycolysis for energy production and this activity leads to production of important amounts of lactate, which are exported into the extracellular milieu, contributing to the acidic microenvironment. In this context, MCTs will play a dual role in the maintenance of the hyper-glycolytic acid-resistant phenotype of cancer, allowing the maintenance of the high glycolytic rates by performing lactate efflux, and pH regulation by the co-transport of protons. Thus, they constitute attractive targets for cancer therapy, which have been little explored. Here we review the literature on the role of MCTs in solid tumors in different locations, such as colon, central nervous system, breast, lung, gynecologic tract, prostate, stomach, however, there are many conflicting results and in most cases there are no functional studies showing the dependence of the tumors on MCT expression and activity. Additional studies on MCT expression in other tumor types, confirmation of the results already published as well as additional functional studies are needed to deeply understand the role of MCTs in cancer maintenance and aggressiveness.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Lactate utilization by tumors is dependent on monocarboxylate transporters (MCTs) (Figure 3), which are highly expressed in a variety of tumors (Pinheiro et al., 2012).”
From Targeting Metabolism for Cancer Therapy (2017) · cites this paper as Pinheiro et al., 2012
Citations
Cites
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
Why Do Cancers Have High Aerobic Glycolysis?
Gatenby, R. A., & Gillies, R. J. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1478 · Cited by 4,784
Kim, J.-W., Tchernyshyov, I., Semenza, G. L., & Dang, C. V. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.002 · Cited by 3,905
DeBerardinis, R. J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., & Thompson, C. B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709747104 · Cited by 2,622
HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption
Papandreou, I., Cairns, R. A., Fontana, L., Lim, A. L., & Denko, N. C. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.012 · Cited by 2,267
Inhibitory effect of tumor cell-derived lactic acid on human T cells
Fischer, K., Hoffmann, P., Voelkl, S., Meidenbauer, N., Ammer, J., Edinger, M., Gottfried, E., Schwarz, S., Rothe, G., Hoves, S., et al. (2007) · Blood · doi:10.1182/blood-2006-07-035972 · Cited by 1,946
Regulation of Mammalian O 2 Homeostasis by Hypoxia-Inducible Factor 1
Semenza, G. L. (1999) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.15.1.551 · Cited by 1,914 · cited 1×
“The frequency and severity of tumor hypoxia and its association with malignant progression make the hypoxiainduced metabolic adaptations promising targets for cancer therapy (Dang & Semenza 1999).”
BackgroundTargeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice
Sonveaux, P., Végran, F., Schroeder, T., Wergin, M., Verrax, J., Rabbani, Z. N., Saedeleer, C. J. D., Kennedy, K. M., Diepart, C., Jordan, B. F., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36843 · Cited by 1,635
Differential Roles of Hypoxia-Inducible Factor 1α (HIF-1α) and HIF-2α in Hypoxic Gene Regulation
Hu, C.-J., Wang, L.-Y., Chodosh, L. A., Keith, B., & Simon, M. C. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.24.9361-9374.2003 · Cited by 1,386
The proton-linked monocarboxylate transporter (MCT) family: structure, function and regulation
Halestrap, A. P., & Price, N. T. (1999) · Biochemical Journal · doi:10.1042/bj3430281 · Cited by 1,346
Hypoxia-inducible expression of tumor-associated carbonic anhydrases.
Wykoff, C. C., Beasley, N. J. P., Watson, P. H., Turner, K., Pastorek, J., Sibtain, A., Wilson, G. D., Turley, H., Talks, K., Maxwell, P. H., et al. (2000) · PubMed · Cited by 1,260
Energy metabolism in tumor cells
Moreno‐Sánchez, R., Rodríguez‐Enríquez, S., Marín‐Hernández, Á., & Saavedra, E. (2007) · FEBS Journal · doi:10.1111/j.1742-4658.2007.05686.x · Cited by 1,121
Oncogenic alterations of metabolism
Dang, C. V., & Semenza, G. L. (1999) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(98)01344-9 · Cited by 1,106
Hypoxia-inducible factor 1: master regulator of O2 homeostasis
Semenza, G. L. (1998) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(98)80016-6 · Cited by 1,092
Halestrap, A. P., & Meredith, D. (2004) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-003-1067-2 · Cited by 1,047
The Transporter Classification Database (TCDB): recent advances
Saier, M. H., Reddy, V. S., Tsu, B. V., Ahmed, M. S., Li, C., & Moreno‐Hagelsieb, G. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv1103 · Cited by 1,010
Ullah, M. S., Davies, A. J., & Halestrap, A. P. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511397200 · Cited by 894
Lu, H., Forbes, R. A., & Verma, A. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202487200 · Cited by 856
Walenta, S., Wetterling, M., Lehrke, M., Schwickert, G., Sundfør, K., Rofstad, E. K., & Mueller‐Klieser, W. (2000) · PubMed · Cited by 817
Regulation of glut1 mRNA by Hypoxia-inducible Factor-1
Chen, C., Pore, N., Behrooz, A., Ismail‐Beigi, F., & Maity, A. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010144200 · Cited by 769
Evidence Supporting the Existence of an Activity-Dependent Astrocyte-Neuron Lactate Shuttle
Pellerin, L., Pellegri, G., Bittar, P. G., Charnay, Y., Bouras, C., Martin, J., Stella, N., & Magistretti, P. J. (1998) · Developmental Neuroscience · doi:10.1159/000017324 · Cited by 757
Chiche, J., Ilc, K., Laferrière, J., Trottier, E., Dayan, F., Mazure, N. M., Brahimi-Horn, M. C., & Pouysségur, J. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-2470 · Cited by 751
Identification of monocarboxylate transporter 8 as a specific thyroid hormone transporter
Friesema, E. C. H., Ganguly, S., Abdalla, A., Fox, J. E. M., Halestrap, A. P., & Visser, T. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300909200 · Cited by 725
Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH
Švastová, E., Hulı́ková, A., Rafajová, M., Zat'ovičová, M., Gibadulinová, A., Casini, A., Cecchi, A., Scozzafava, A., Supuran, C. T., Pastorek, J., et al. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.10.043 · Cited by 711
Kirk, P. B., Wilson, M. C., Heddle, C., Brown, M. H., Barclay, A. N., & Halestrap, A. P. (2000) · The EMBO Journal · doi:10.1093/emboj/19.15.3896 · Cited by 703
Hypoxia, Clonal Selection, and the Role of HIF-1 in Tumor Progression
Semenza, G. L. (2000) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409230091169186 · Cited by 657
Brizel, D. M., Schroeder, T., Scher, R. L., Walenta, S., Clough, R. W., Dewhirst, M. W., & Mueller‐Klieser, W. (2001) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(01)01630-3 · Cited by 596
DIMMER, K.-S., Friedrich, B., Lang, F. J. W., Deitmer, J. W., & Bröer, S. (2000) · Biochemical Journal · doi:10.1042/bj3500219 · Cited by 590
Hypoxic Regulation of Lactate Dehydrogenase A
Firth, J. D., Ebert, B. L., & Ratcliffe, P. J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.36.21021 · Cited by 576
Greijer, A. E., van der Groep, P., Kemming, D., Shvarts, A., Semenza, G., Meijer, G. A., van de Wiel, M. A., Beliën, J. A. M., van Diest, P. J., & van der Wall, E. (2005) · The Journal of Pathology · doi:10.1002/path.1778 · Cited by 450
Anticancer Targets in the Glycolytic Metabolism of Tumors: A Comprehensive Review
Porporato, P. E., Dhup, S., Dadhich, R. K., Copetti, T., & Sonveaux, P. (2011) · Frontiers in Pharmacology · doi:10.3389/fphar.2011.00049 · Cited by 449
LeFloch, R., Chiche, J., Marchiq, I., Naiken, T., Ilc, K., Murray, C. M., Critchlow, S. E., Roux, D., Simon, M., & Pouysségur, J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106123108 · Cited by 445
Koukourakis, M. I., Giatromanolaki, A. N., Harris, A. L., & Sivridis, E. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3260 · Cited by 438
CD44 in Cancer Progression: Adhesion, Migration and Growth Regulation
Marhaba, R., & Zöller, M. (2004) · Journal of Molecular Histology · doi:10.1023/b:hijo.0000032354.94213.69 · Cited by 437
The Transporter Classification Database: recent advances
Saier, M. H., Yen, M. R., Noto, K., Tamang, D. G., & Elkan, C. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn862 · Cited by 414
Warnecke, C., Zaborowska, Z., Kurreck, J., Erdmann, V. A., Frei, U. A., Wiesener, M. S., & Eckardt, K. (2004) · The FASEB Journal · doi:10.1096/fj.04-1640fje · Cited by 406
Halestrap, A. P., & Denton, R. M. (1974) · Biochemical Journal · doi:10.1042/bj1380313 · Cited by 383
Regulation of T Lymphocyte Metabolism
Frauwirth, K. A., & Thompson, C. B. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.8.4661 · Cited by 371
cDNA Cloning of MCT2, a Second Monocarboxylate Transporter Expressed in Different Cells than MCT1
Garcia, C. K., Brown, M. S., Pathak, R., & Goldstein, J. L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.4.1843 · Cited by 351
Aerobic glycolysis during lymphocyte proliferation
Wang, T., Marquardt, C. A., & Foker, J. E. (1976) · Nature · doi:10.1038/261702a0 · Cited by 333
Fox, J. E. M., Meredith, D., & Halestrap, A. P. (2000) · The Journal of Physiology · doi:10.1111/j.1469-7793.2000.00285.x · Cited by 331
Wilson, M. C., Meredith, D., Fox, J. E. M., Manoharan, C., Davies, A. J., & Halestrap, A. P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411950200 · Cited by 318
Lactate-proton cotransport in skeletal muscle
Juel, C. (1997) · Physiological Reviews · doi:10.1152/physrev.1997.77.2.321 · Cited by 313
Bröer, S., SCHNEIDER, H.-P., Bröer, A., Rahman, B., Hamprecht, B., & Deitmer, J. W. (1998) · Biochemical Journal · doi:10.1042/bj3330167 · Cited by 312
Nabeshima, K., Iwasaki, H., Koga, K., Hojo, H., Suzumiya, J., & Kikuchi, M. (2006) · Pathology International · doi:10.1111/j.1440-1827.2006.01972.x · Cited by 298
Gallagher, S. M., Castorino, J. J., Wang, D., & Philp, N. J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3184 · Cited by 289
Hypoxia-Inducible Factor 1: Control of Oxygen Homeostasis in Health and Disease
Semenza, G. L. (2001) · Pediatric Research · doi:10.1203/00006450-200105000-00002 · Cited by 281
Characterization of the high-affinity monocarboxylate transporter MCT2 in Xenopus laevis oocytes
Bröer, S., Bröer, A., SCHNEIDER, H.-P., Stegen, C. F., Halestrap, A. P., & Deitmer, J. W. (1999) · Biochemical Journal · doi:10.1042/0264-6021:3410529 · Cited by 273
CD147 immunoglobulin superfamily receptor function and role in pathology
Iacono, K. T., Brown, A. L., Greene, M. I., & Saouaf, S. J. (2007) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2007.08.014 · Cited by 272
Aerobically Derived Lactate Stimulates Revascularization and Tissue Repair via Redox Mechanisms
Hunt, T. K., Aslam, R. S., Beckert, S., Wagner, S., Ghani, Q. P., Hussain, M., Roy, S., & Sen, C. K. (2007) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1674 · Cited by 263
Ovens, M. J., Davies, A. J., Wilson, M. C., Murray, C. M., & Halestrap, A. P. (2009) · Biochemical Journal · doi:10.1042/bj20091515 · Cited by 260
Roles of the multifunctional glycoprotein, emmprin (basigin; CD147), in tumour progression
Li, Y., Zucker, S., & Toole, B. P. (2005) · Thrombosis and Haemostasis · doi:10.1160/th04-08-0536 · Cited by 256
Increased expression of monocarboxylate transporters 1, 2, and 4 in colorectal carcinomas
Pinheiro, C. M., Longatto‐Filho, A., Scapulatempo‐Neto, C., Ferreira, L., Martins, S. F. F., Pellerin, L., Rodrigues, M., Alves, V. A. F., Schmitt, F. C., & Baltazar, F. (2008) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-007-0558-5 · Cited by 254
Self-citationCorrelation of high lactate levels in head and neck tumors with incidence of metastasis.
Walenta, S., Salameh, A., Lyng, H., Evensen, J. F., Mitze, M., Rofstad, E. K., & Mueller‐Klieser, W. (1997) · Europe PMC (PubMed Central) · Cited by 251
Kim, D. K., Kanai, Y., Chairoungdua, A., Matsuo, H., Ho, S., & Endou, H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009462200 · Cited by 235
Philp, N. J., Ochrietor, J. D., Rudoy, C., Muramatsu, T., & Linser, P. J. (2003) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.02-0552 · Cited by 235
Lactate Stimulates Fibroblast Expression of Hyaluronan and CD44: The Warburg Effect Revisited
Stern, R., Shuster, S., Neudecker, B. A., & Formby, B. (2002) · Experimental Cell Research · doi:10.1006/excr.2002.5508 · Cited by 230
Jadvar, H., Alavi, A. A., & Gambhir, S. S. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.054098 · Cited by 226
Correlation of high lactate levels in human cervical cancer with incidence of metastasis.
Schwickert, G., Walenta, S., Sundfør, K., Rofstad, E. K., & Mueller-Klieser, W. (1995) · PubMed · Cited by 225
Hyaluronan: A constitutive regulator of chemoresistance and malignancy in cancer cells
Toole, B. P., & Slomiany, M. G. (2008) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2008.03.009 · Cited by 224
Adaptive landscapes and emergent phenotypes: why do cancers have high glycolysis?
Gillies, R. J., & Gatenby, R. A. (2007) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-007-9085-y · Cited by 219
Lonidamine, a selective inhibitor of aerobic glycolysis of murine tumor cells.
Floridi, A., Paggi, M. G., Marcante, M. L., Silvestrini, B., Caputo, A., & Martino, C. D. (1981) · PubMed · Cited by 211
Hypoxia-inducible factor 1 and the molecular physiology of oxygen homeostasis
Semenza, G. L. (1998) · Journal of Laboratory and Clinical Medicine · doi:10.1016/s0022-2143(98)90091-9 · Cited by 207
Quennet, V., Yaromina, A., Zips, D., Rosner, A., Walenta, S., Baumann, M. A., & Mueller‐Klieser, W. (2006) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2006.08.012 · Cited by 197
Substrate‐induced regulation of the human colonic monocarboxylate transporter, MCT1
Cuff, M. A., Lambert, D., & Shirazi‐Beechey, S. P. (2002) · The Journal of Physiology · doi:10.1113/jphysiol.2001.014241 · Cited by 195
Colen, C. B., Shen, Y., Ghoddoussi, F., Yu, P., Francis, T. B., Koch, B. J., Monterey, M. D., Galloway, M. P., Sloan, A. E., & Mathupala, S. P. (2011) · Neoplasia · doi:10.1593/neo.11134 · Cited by 194
Metabolic changes during carcinogenesis: Potential impact on invasiveness
Smallbone, K., Gatenby, R. A., Gillies, R. J., Maini, P. K., & Gavaghan, D. J. (2006) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2006.09.010 · Cited by 190
de Heredia, F. P., Wood, I. S., & Trayhurn, P. (2009) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-009-0750-3 · Cited by 190
Monocarboxylate transporter 1 is up‐regulated in basal‐like breast carcinoma
Pinheiro, C. M., Albergaria, A., Paredes, J., Sousa, B., Dufloth, R. M., Vieira, D. S. C., Schmitt, F. C., & Baltazar, F. (2010) · Histopathology · doi:10.1111/j.1365-2559.2010.03560.x · Cited by 188
Self-citationHyaluronan, CD44 and Emmprin: Partners in cancer cell chemoresistance
Toole, B. P., & Slomiany, M. G. (2008) · Drug Resistance Updates · doi:10.1016/j.drup.2008.04.002 · Cited by 188
Brand, K. (1985) · Biochemical Journal · doi:10.1042/bj2280353 · Cited by 187
Izumi, H., Takahashi, M., Uramoto, H., Nakayama, Y., Oyama, T., Wang, K., Sasaguri, Y., Nishizawa, S., & Kohno, K. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2011.01908.x · Cited by 180
Pértega‐Gomes, N., Vizcaino, J. R., Miranda‐Gonçalves, V., Pinheiro, C. M., Silva, J., Pereira, H., Monteiro, P., Henrique, R., Reis, R. M., Lopes, C., et al. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-312 · Cited by 180
Self-citationmiR-124 is frequently down-regulated in medulloblastoma and is a negative regulator of SLC16A1
Li, K. K., Pang, J. C., Ching, A. K.-K., Wong, C. K., Kong, X., Wang, Y., Zhou, L., Chen, Z., & Ng, H. (2009) · Human Pathology · doi:10.1016/j.humpath.2009.02.003 · Cited by 179
Philp, N. J., Yoon, H., & Grollman, E. F. (1998) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1998.274.6.r1824 · Cited by 175
Pinheiro, C. M., Reis, R. M., Ricardo, S. A. V., Longatto‐Filho, A., Schmitt, F. C., & Baltazar, F. (2010) · BioMed Research International · doi:10.1155/2010/427694 · Cited by 171
Self-citationFang, J., Quiñones, Q. J., Holman, T. L., Morowitz, M. J., Wang, Q., Zhao, H., Sivo, F., Maris, J. M., & Wahl, M. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.026245 · Cited by 171
Schneiderhan, W., Scheler, M., Holzmann, K.-H., Marx, M., Gschwend, J. E., Buchholz, M. A., Gress, T. M., Seufferlein, T. T. W., Adler, G., & Oswald, F. (2009) · Gut · doi:10.1136/gut.2009.181412 · Cited by 164
Deora, A. A., Philp, N. J., Hu, J. G., Bok, D., & Rodriguez-Boulan, E. J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504419102 · Cited by 151
Mazurek, S., Zwerschke, W., Jansen‐Dürr, P., & EIGENBRODT, E. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3560247 · Cited by 147
Mathupala, S. P., Parajuli, P., & Sloan, A. E. (2004) · Neurosurgery · doi:10.1227/01.neu.0000143034.62913.59 · Cited by 147
Jackson, V. N., Price, N. T., CARPENTER, L., & Halestrap, A. P. (1997) · Biochemical Journal · doi:10.1042/bj3240447 · Cited by 146
Slomiany, M. G., Grass, G. D., Robertson, A. D., Xiao, Y., Maria, B. L., Beeson, C. C., & Toole, B. P. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2491 · Cited by 144
Endothelial cell response to lactate: Implication of PAR modification of VEGF
Kumar, V. B. S., Viji, R. I., Kiran, M. S., & Sudhakaran, P. R. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20955 · Cited by 143
Regulation of intracellular pH in human melanoma: potential therapeutic implications.
Wahl, M., Owen, J. A., Burd, R., Herlands, R., Nogami, S. S., Rodeck, U., Berd, D., Leeper, D. B., & Owen, C. S. (2002) · PubMed · Cited by 141
Lambert, D., Wood, I. S., Ellis, A., & Shirazi‐Beechey, S. P. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600264 · Cited by 135
Su, J., Chen, X., & Kanekura, T. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.07.034 · Cited by 131
Inhibition of lactate transport and glycolysis in Ehrlich ascites tumor cells by bioflavonoids
Belt, J. A., Thomas, J. A., Buchsbaum, R., & Racker, E. (1979) · Biochemistry · doi:10.1021/bi00583a011 · Cited by 128
Studies of the membrane topology of the rat erythrocyte H+/lactate cotransporter (MCT1)
Poole, R. C., Sansom, C., & Halestrap, A. P. (1996) · Biochemical Journal · doi:10.1042/bj3200817 · Cited by 128
Baumann, M. U., Zamudio, S., & Illsley, N. P. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00075.2007 · Cited by 127
Ladanyi, M., Antonescu, C. R., Drobnjak, M., Baren, A., Lui, M. Y., Golde, D. W., & Cordon‐Cardo, C. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62548-5 · Cited by 125
Kido, Y., Tamai, I., Okamoto, M., Suzuki, F., & Tsuji, A. (2000) · Pharmaceutical Research · doi:10.1023/a:1007518525161 · Cited by 123
Hao, J., Chen, H., Madigan, M. C., Cozzi, P. J., Beretov, J., Xiao, W., Delprado, W., Russell, P. J., & Li, Y. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605839 · Cited by 119
Bergersen, L. H., Jóhannsson, E., Veruki, M. L., Nagelhus, E. A., Halestrap, A. P., Sejersted, O. M., & Ottersen, O. P. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00427-8 · Cited by 118
Blocking CD147 induces cell death in cancer cells through impairment of glycolytic energy metabolism
Baba, M., Inoue, M., Itoh, K., & Nishizawa, Y. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.06.122 · Cited by 110
Mazurek, S., Zwerschke, W., Jansen‐Dürr, P., & EIGENBRODT, E. (2001) · Oncogene · doi:10.1038/sj.onc.1204792 · Cited by 107
Pinheiro, C. M., Longatto‐Filho, A., Ferreira, L., Pereira, S. M. M., Etlinger, D., Moreira, M. A. R., Jubé, L. F., Queiroz, G. S., Schmitt, F. C., & Baltazar, F. (2008) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0b013e31817b5b40 · Cited by 103
Self-citationLung cancer: An organized cellular and metabolic domain
Koukourakis, M. I., Giatromanolaki, A. N., Bougioukas, G., & Sivridis, E. (2007) · Cancer Biology & Therapy · doi:10.4161/cbt.6.9.4635 · Cited by 100
Pinheiro, C. M., Longatto‐Filho, A., Simões, K., Jacob, C. E., Bresciani, C. J. C., Zilberstein, B., Cecconello, I., Alves, V. A. F., Schmitt, F. C., & Baltazar, F. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2009.06.018 · Cited by 95
Self-citationChen, H., Wang, L., Beretov, J., Hao, J., Xiao, W., & Li, Y. (2010) · Clinical & Experimental Metastasis · doi:10.1007/s10585-010-9345-9 · Cited by 92
Spector, J. A., Mehrara, B. J., Greenwald, J. A., Saadeh, P. B., Steinbrech, D. S., Bouletreau, P. J., Smith, L. P., & Longaker, M. T. (2001) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2001.280.1.c72 · Cited by 92
Expression of monocarboxylate transporter MCT1 in normal and neoplastic human CNS tissues
Froberg, M. K., Gerhart, D. Z., Enerson, B. E., Manivel, C. J., Guzman‐Paz, M., Seacotte, N., & Drewes, L. R. (2001) · Neuroreport · doi:10.1097/00001756-200103260-00030 · Cited by 85
Metabolic mapping with bioluminescence: basic and clinical relevance
Walenta, S., Schroeder, T., & Mueller‐Klieser, W. (2002) · Biomolecular Engineering · doi:10.1016/s1389-0344(01)00107-1 · Cited by 84
Inhibitory effects of statins on human monocarboxylate transporter 4
Kobayashi, M., Otsuka, Y., Itagaki, S., Hirano, T., & Iseki, K. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.02.043 · Cited by 81
Interaction of monocarboxylate transporter 4 with β1-integrin and its role in cell migration
Gallagher, S. M., Castorino, J. J., & Philp, N. J. (2008) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00430.2008 · Cited by 79
Ben-Horin, H., Tassini, M., Vivi, A., Navon, G., & Kaplan, O. (1995) · PubMed · Cited by 78
METABOLIC REMODELING OF MALIGNANT GLIOMAS FOR ENHANCED SENSITIZATION DURING RADIOTHERAPY
Colen, C. B., Seraji‐Bozorgzad, N., Marples, B., Galloway, M. P., Sloan, A. E., & Mathupala, S. P. (2006) · Neurosurgery · doi:10.1227/01.neu.0000249218.65332.bf · Cited by 76
Wang, Q., & Morris, M. E. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.012369 · Cited by 75
Reduced Expression of GNA11 and Silencing of MCT1 in Human Breast Cancers
Asada, K., Miyamoto, K., Fukutomi, T., Tsuda, H., Yagi, Y., Wakazono, K., Oishi, S., Fukui, H., Sügimura, T., & Ushijima, T. (2003) · Oncology · doi:10.1159/000070297 · Cited by 73
Monocarboxylate Transporters 1 and 4 Are Associated with CD147 in Cervical Carcinoma
Pinheiro, C. M., Longatto‐Filho, A., Pereira, S. M. M., Etlinger, D., Moreira, M. A. R., Jubé, L. F., Queiroz, G. S., Schmitt, F. C., & Baltazar, F. (2009) · Disease Markers · doi:10.1155/2009/169678 · Cited by 73
Self-citationGrollman, E. F., Philp, N. J., McPhie, P., Ward, R. D., & Sauer, B. (2000) · Biochemistry · doi:10.1021/bi000464+ · Cited by 72
Monocarboxylate transporters 1 and 4 are associated with CD147 in cervical carcinoma.
Pinheiro, C. M., Longatto‐Filho, A., Pereira, S. M. M., et al. (2009) · PubMed · doi:10.3233/dma-2009-0596 · Cited by 64
Self-citationCarpenter, L., Poole, R. C., & Halestrap, A. P. (1996) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(95)00254-5 · Cited by 62
Poole, R. C., Cranmer, S. L., Halestrap, A. P., & Levi, A. J. (1990) · Biochemical Journal · doi:10.1042/bj2690827 · Cited by 60
Tumor M2-PK and glutaminolytic enzymes in the metabolic shift of tumor cells.
Mazurek, S., Grimm, H., Oehmke, M. J., Weisse, G., Teigelkamp, S., & EIGENBRODT, E. (2000) · PubMed · Cited by 55
Ben‐Yoseph, O., Lyons, J. C., Song, C. W., & Ross, B. D. (1998) · Journal of Neuro-Oncology · doi:10.1023/a:1005819604858 · Cited by 50
Tumor Microenvironment Modulates Hyaluronan Expression: The Lactate Effect
Rudrabhatla, S. R., Mahaffey, C. L., & Mummert, M. E. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700255 · Cited by 44
MAKUC, J., Cappellaro, C., & Boles, E. (2004) · FEMS Yeast Research · doi:10.1016/j.femsyr.2004.06.003 · Cited by 29
Ritzhaupt, A., Wood, I. S., Ellis, A., Hosie, K. B., & Shirazi‐Beechey, S. P. (1998) · Biochemical Society Transactions · doi:10.1042/bst026s120 · Cited by 26
Cited by
Sorted by citations
Tumor glycolysis as a target for cancer therapy: progress and prospects
Ganapathy‐Kanniappan, S., & Geschwind, J.-F. H. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-152 · Cited by 1,428
HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations
Semenza, G. L. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67230 · Cited by 1,335
Targeting Metabolism for Cancer Therapy
Luengo, A., Gui, D. Y., & Vander Heiden, M. G. (2017) · Cell Chemical Biology · doi:10.1016/j.chembiol.2017.08.028 · Cited by 971
Monocarboxylate transporters in cancer
Payen, V. L., Mina, E., Hée, V. F. V., Porporato, P. E., & Sonveaux, P. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.07.006 · Cited by 688
San-Millán, I., & Brooks, G. A. (2016) · Carcinogenesis · doi:10.1093/carcin/bgw127 · Cited by 640
Metadata
- Authors
- Pinheiro, C., Longatto-Filho, A., Azevedo-Silva, J., Casal, M., Schmitt, F. C., & Baltazar, F.
- Affiliations
- University of Minho (PT)
- Universidade do Porto (PT)
- Corresponding author
- Baltazar, Fátima
- Venue
- Journal of Bioenergetics and Biomembranes
- Published
- 2012-02
- Volume
- 44
- Issue
- 1
- Pages
- 127-139
- ISSN
- 0145-479X (ISSN-L)
- 1573-6881
- OpenAlex
- W2064926668
- Cited by
- 368
- References
- 118
- Citations by year
- 2026: 4 · 2025: 10 · 2024: 13 · 2023: 23 · 2022: 20 · 2021: 32 · 2020: 34 · 2019: 40 · 2018: 24 · 2017: 33 · 2016: 35 · 2015: 30 · 2014: 33 · 2013: 28 · 2012: 9
- FWCI
- 2.41
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- other-oa
- www.springer.com/tdm (tdm)
- Locations
- Journal of Bioenergetics and Biomembranes (publishedVersion)
- PubMed (publishedVersion)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, other-oa)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Keywords
- monocarboxylate transporters, lactate transport, pyruvate transport, tumor acidification, tumor microenvironment pH, glycolysis, proton symport, cancer therapy targets, solid tumors, colon cancer, breast cancer, lung cancer, gynecologic cancer, prostate cancer, gastric cancer
- MeSH terms
- Monocarboxylate Transport Protein 1, Amino Acid Sequence, Animals, Multigene Family, Glycolysis, Humans, Hydrogen-Ion Concentration, Molecular Sequence Data, Neoplasms, Phylogeny, Species Specificity, Lactic Acid, Monocarboxylic Acid Transporters, Symporters, Metabolic Networks and Pathways
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review